Statistics

Total Visits

Views
Preliminary safety results of regorafenib (REG) as a single agent for first-line treatment of frail and/or unfit for polychemotherapy patients (pts) with metastatic colorectal cancer (mCRC): A phase II study of the Spanish Cooperative Group for Digestive37

Select a period of time:

Number of views in the range

Views
Preliminary safety results of regorafenib (REG) as a single agent for first-line treatment of frail and/or unfit for polychemotherapy patients (pts) with metastatic colorectal cancer (mCRC): A phase II study of the Spanish Cooperative Group for Digestive23

Views

Views
October 20240
November 20244
December 20240
January 20250
February 20253
March 202516
April 20250
Download CSV file
 untranslated
 untranslated

Top country views

Views
Singapore16
United States4
Germany1
Finland1
United Kingdom1
 

Top cities views

Views
Frankfurt am Main1
Helsinki1